Written by Klarity Editorial Team
Published: Jul 17, 2026

Last updated: July 17, 2026
Quick Facts — Cigna + Depression in Hawaii (2026)
• PBM: Express Scripts (ESI) — manages Cigna’s prescription drug benefits in Hawaii
• Generic antidepressants (SSRIs, SNRIs, bupropion, mirtazapine): typically Tier 1–2, no prior authorization required
• Brand-name antidepressants: typically Tier 3–4, step therapy or PA may apply
• Trintellix, Auvelity: Tier 3–4, prior authorization likely required
• Spravato (esketamine): specialty tier, PA + REMS program required
• Cigna PA Policy IP0477: stimulant-specific — does NOT apply to depression medications
• EPCS (electronic prescribing): HRS § 329-38.5 covers Schedule II only — all standard antidepressants are non-scheduled, entirely inapplicable; Spravato is Schedule III, also NOT subject to HRS § 329-38.5
• HI parity: Haw. Rev. Stat. § 431M-1 et seq. (commercial plans)
If you have Cigna insurance in Hawaii and are seeking treatment for depression, understanding what your plan may cover can help you plan your care. Cigna’s commercial plans in Hawaii use Express Scripts (ESI) as the pharmacy benefit manager, and coverage for depression medications and therapy typically follows established parity law requirements under Hawaii state law. This guide breaks down how Cigna’s depression coverage works in Hawaii in 2026, including formulary details, prior authorization rules, and how to verify your benefits.
See If You May Qualify for Depression Treatment →
Cigna commercial plans in Hawaii partner with Express Scripts (ESI) to administer prescription drug benefits. ESI manages a national formulary that determines which medications are covered, at what tier, and whether prior authorization or step therapy is required.
Coverage details — including tier placement, cost-sharing amounts, and PA requirements — may vary depending on whether your plan is an HMO, PPO, or employer-sponsored self-funded plan. Always verify your specific benefits through myCigna.com or by calling the member services number on your ID card before beginning treatment.
The following table reflects typical ESI tier placement for commonly prescribed depression medications. Actual coverage may differ by plan; confirm with Cigna or ESI directly.
| Medication | Type | ESI Tier | Prior Authorization |
|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Tier 1–2 | Typically not required |
| Escitalopram (generic Lexapro) | SSRI | Tier 1–2 | Typically not required |
| Fluoxetine (generic Prozac) | SSRI | Tier 1–2 | Typically not required |
| Paroxetine (generic Paxil) | SSRI | Tier 1–2 | Typically not required |
| Citalopram (generic Celexa) | SSRI | Tier 1–2 | Typically not required |
| Venlafaxine (generic Effexor) | SNRI | Tier 1–2 | Typically not required |
| Duloxetine (generic Cymbalta) | SNRI | Tier 1–2 | Typically not required |
| Bupropion (generic Wellbutrin) | NDRI | Tier 1–2 | Typically not required |
| Mirtazapine (generic Remeron) | TeCA | Tier 1–2 | Typically not required |
| Amitriptyline, Nortriptyline (TCAs) | TCA | Tier 1–2 | Typically not required |
| Brand SSRIs/SNRIs (e.g., Lexapro brand) | SSRI/SNRI brand | Tier 3–4 | Step therapy often required |
| Trintellix (vortioxetine) | Serotonin modulator | Tier 3–4 | PA typically required |
| Auvelity (bupropion/dextromethorphan) | NMDA antagonist combo | Tier 3–4 | PA typically required |
| Spravato (esketamine nasal spray) | NMDA antagonist | Specialty | PA + REMS required |
Source: ESI formulary, 2026. Verify current tier placement at express-scripts.com or cigna.com.
For most generic antidepressants — SSRIs, SNRIs, bupropion, mirtazapine, and TCAs — prior authorization is typically not required under ESI’s formulary. These medications are generally accessible at Tier 1–2 cost-sharing levels.
Brand-name antidepressants and newer agents like Trintellix and Auvelity more commonly require PA, often paired with step therapy documentation showing a trial of a generic equivalent has been attempted.
Spravato (esketamine) requires both prior authorization and enrollment in the Spravato REMS (Risk Evaluation and Mitigation Strategy) program. It is administered in certified healthcare settings only.
No. Cigna’s PA Policy IP0477 (effective May 15, 2026) is specifically a stimulant PA policy — it applies exclusively to ADHD stimulant medications such as amphetamine salts, methylphenidate, and lisdexamfetamine. Depression medications — including SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, Auvelity, and Spravato — are not affected by IP0477. Their PA requirements are governed by standard ESI formulary management rules, not by the stimulant-specific IP0477 policy.
Hawaii’s electronic prescribing for controlled substances (EPCS) law, Haw. Rev. Stat. § 329-38.5, requires electronic prescribing for Schedule II controlled substances only.
The great majority of depression medications — SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, and Auvelity — are not controlled substances. HRS § 329-38.5 does not apply to them at all.
Spravato (esketamine) is a Schedule III controlled substance. Importantly, HRS § 329-38.5 covers Schedule II only — Spravato is Schedule III and is NOT subject to Hawaii’s EPCS requirement. This is a meaningful distinction from states like West Virginia, where W. Va. Code § 60A-4-403a covers all controlled substances (including Schedule III). In Hawaii, only Schedule II prescriptions require EPCS. Spravato is instead administered in a certified clinical setting under the FDA’s REMS program, which has its own documentation requirements separate from state EPCS law.
Hawaii’s mental health parity law, Haw. Rev. Stat. § 431M-1 et seq., requires that commercial health insurers — including Cigna — provide mental health and substance use disorder benefits on terms no more restrictive than those applied to comparable medical and surgical benefits.
In practice, this typically means:
Important: Hawaii’s parity law applies to fully insured commercial plans. Self-funded employer plans are governed by the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and are generally exempt from state parity statutes under ERISA. If you are unsure whether your Cigna plan is fully insured or self-funded, check your plan documents or call Cigna member services.
Hawaii’s Prepaid Health Care Act (Haw. Rev. Stat. § 393) is a unique state employer mandate that requires most Hawaii employers to provide health coverage for employees working 20 or more hours per week. This law applies to Cigna’s commercial plans sold to Hawaii employers.
While the Prepaid Health Care Act does not specifically mandate depression treatment coverage, it ensures that most working Hawaii residents with Cigna employer-sponsored plans have access to the mental health benefits in their plan — which, in combination with Hawaii’s parity law (§ 431M-1), means depression treatment must generally be covered on equal terms with physical health care.
Employees working fewer than 20 hours per week, or those covered under self-funded ERISA plans, may have different coverage protections. Contact the Hawaii Department of Labor and Industrial Relations (DLIR) at 1-808-586-8777 with questions about the Prepaid Health Care Act.
Cigna commercial plans in Hawaii may provide coverage for a range of depressive disorders, subject to medical necessity review. Commonly covered conditions may include:
Coverage typically encompasses both medication management and outpatient therapy, including individual therapy, group therapy, and intensive outpatient programs (IOP). Telehealth visits for depression are generally covered under Cigna plans, often at the same cost-sharing as in-person visits.
Klarity Health connects patients with a network of 2,000+ licensed providers across Hawaii and the continental United States. Our providers offer telehealth depression evaluations and medication management, typically within days of your first appointment. Many Cigna plans in Hawaii may cover telehealth visits with our providers — verify your benefits before booking.
Check If You May Qualify for Depression Treatment →
Cigna commercial plans in Hawaii typically cover outpatient therapy for depression, including individual and group therapy sessions. Hawaii’s parity law (Haw. Rev. Stat. § 431M-1) generally requires that mental health therapy benefits be covered no more restrictively than comparable medical benefits. Check your specific plan’s behavioral health benefits at myCigna.com or call member services to confirm your copay or coinsurance amounts.
No. Cigna’s PA Policy IP0477 is a stimulant-specific policy that applies only to ADHD medications. It does not apply to antidepressants, including SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, Auvelity, or Spravato. Your antidepressant PA requirements are determined by standard ESI formulary management rules.
Referral requirements depend on your specific plan type. Cigna HMO plans in Hawaii may require a referral from your primary care provider (PCP) before seeing a psychiatrist, while PPO plans typically do not. Review your plan documents or call 1-800-244-6224 to confirm.
No. Hawaii’s EPCS law (HRS § 329-38.5) applies only to Schedule II controlled substances. Standard antidepressants — SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, and Auvelity — are not controlled substances and are not subject to EPCS. Spravato (esketamine) is Schedule III, which is also not subject to HRS § 329-38.5. Your prescriber may still choose to e-prescribe, but it is not legally mandated for these medications in Hawaii.
If your Cigna claim is denied, you typically have the right to an internal appeal and, if that is unsuccessful, an independent external review. Request a written explanation of the denial, gather clinical documentation from your provider supporting medical necessity, and submit a formal appeal. Hawaii law and federal MHPAEA protections may support your case if the denial appears inconsistent with parity requirements. Contact the Hawaii Insurance Division at 1-808-586-2790 if you need assistance with the appeals process.
The Hawaii Prepaid Health Care Act (HRS § 393) requires most Hawaii employers to provide health coverage but does not mandate specific depression treatment benefits on its own. However, Cigna commercial plans in Hawaii must comply with Hawaii’s mental health parity law (§ 431M-1), which generally requires depression coverage to be offered on equal terms with physical health coverage. The combination of these two laws provides a meaningful coverage floor for most fully insured employer-sponsored Cigna members in Hawaii.
Disclaimer: Coverage varies by individual plan, employer, and plan year. The information in this guide reflects general patterns and publicly available formulary data as of July 2026 and is intended for educational purposes only. It does not constitute a guarantee of coverage. Always verify your specific benefits directly with Cigna before scheduling any appointments or filling prescriptions. Self-funded ERISA plans may differ from state-regulated fully insured plans.
Find the right provider for your needs — select your state to find expert care near you.